New cas9 protein and synthetic gRNA strengthen Thermo Fisher Scientific's portfolio of genome editing products

Infectious diseases: CTRL + ALT + Delete

First-to-market reagents enable native gene overexpression for meaningful gain-of-function studies

DESKGEN Series Libraries are designed and manufactured using the latest CRISPR gene editing techniques and artificial intelligence to deliver a tailored end-to-end solution

Christoph Bock, PhD, talks to contributing editor Tanuja Koppal, PhD, about the new CROP-seq technology for single-cell CRISPR sequencing that his group has developed

By providing access through the global Thermo Fisher channels, Synthego rapidly scales commercial efforts across markets worldwide

 Dr. Feng Zhang nd his team were first to develop and demonstrate successful methods for using an engineered CRISPR-Cas9 system to edit genomes in living mouse and human cells

Conformational changes within protein domains suggest mutations to make hyper-accurate Cas9s

Offers greater accuracy and comprehensive target identification in all human cell types

The launch represents a major step towards therapeutic use of CRISPR